Results for the First Quarter 2023

25. Apr 2023

NOK 82.1. The Vascular business segment continues the positive development and grows at 21.5% in NOK, currency neutral 8.8% growth. The Imaging products grow at 9.4% in NOK, currency neutral decline of 3.7%. Currency neutral…

Medistim is opening a direct sales office in China

3. Apr 2023

More than 60,000 coronary bypass procedures are performed in China annually and the number is expected to continue to grow high single digit in the years to come. Today, about 70% of these procedures are…

Annual Report 2022

31. Mar 2023

Further supported by several high-quality symposia at the largest heart surgery conferences, we achieved 44 % growth in the imaging product portfolio in 2022. And while steadily penetrating the Cardiac bypass market, we also build…

Results for the Fourth Quarter and Preliminary Results for 2022

1. Mar 2023

All major geographical regions drive sales growth. Currency-neutral sales increased by 21.6 % for the quarter and 11.9 % for the year. Currency-neutral sales of own products increase 24.6 % for the quarter and 14.0…

Presentation of Medistim’s Q4 and preliminary year-end results 2022

20. Feb 2023

The financials will be presented via a live webinar on Wednesday, March 1st from 08:00-09:00 (CET). Representatives for the company will be Kari Eian Krogstad (CEO), and Thomas Jakobsen (CFO). The recording will be made available…

Medistim celebrates a long-standing relationship with the Japanese cardiac surgery community

2. Dec 2022

“This is very much a story of a perfect fit between Norwegian technology and Japanese quality standards. Medistim technology has been able to meet expectations of the quality driven Japanese market. There are few arenas…

Results for the third quarter 2022

28. Oct 2022

In the third quarter, total revenue ended at MNOK 116.5 (MNOK 102.1), a 14.0% increase. Sales growth is driven by the USA with a currency-neutral sales increase of 18.7 % for the quarter and 24.1…

New ESVS Guidelines recommend intraoperative ultrasound after CEA

19. Sep 2022

The Guidelines are set to identify luminal thrombus after flow restoration, diagnose intimal flaps and diagnose residual stenoses during surgery. The new recommendation is based on a meta-analysis by Knappich et al. 20212 that shows…

Results for the second quarter and first half 2022

23. Aug 2022

Sales growth is driven by the USA with a currency-neutral sales increase of 28 % for the quarter and 29 % for the first half. Strategic areas of Vascular Surgery and Imaging products show high…

Results for the First Quarter 2022

28. Apr 2022

All-time high sales for a quarter ending at MNOK 116.1 (MNOK 102.6), an increase of 13.2%. Sales growth is driven by the USA with a currency-neutral increase of 34.2%. Currency neutral sales of own products…

Name of cookie	Time of storage	Provider	Description
_ga	2 years	medistim.com	This cookie registers your unique ID upon your visit, to generate statistical data on how you use our website.
_gat	1 day	medistim.com	This cookie is used by Google Analytics to throttle the request rate.
_gid	1 day	medistim.com	This cookie registers a unique ID that is used to generate statistical data on how you use our website.
p.gif	Session	typekit.net	This cookie keeps track of special fonts used on the site for internal analysis. This cookie does not register any visitor data.

Name of cookie	Time of storage	Provider	Description
ads/ga.audiences	Session	google.com	This cookie is used by Google Adwords to re-engage visitors that are likely to convert to customers based on the visitor's online behaviour across websites
r/collect	Session	doubleclick.net	This cookie is used to send data to Google Analytics about the visitor's device and behavior. The cookie tracks visitors across devices and marketing channels.